We work to improve the quality of life of patients with spinal cord injuries, strokes, and other diseases affecting the central nervous system.
We reposition drugs such as rimonabant to improve the lives of patients.
About Sinfatin
In Sinfatin SL We are committed to researching new uses for marketed medications. We seek solutions for patients with diseases of the nervous system through drug repositioning, which allows us to reduce development times and offer safe and effective solutions to patients.
We have an expert team composed of physicians, biologists, pharmacists, and professionals with solid training and extensive clinical and scientific experience. Our team is committed to a common goal: improve the quality of life of people living with spinal cord injury, stroke and other central nervous system (CNS) diseases.
Therapeutic areas
At Sinfatin we work to offer real solutions to patients with diseases of the central nervous systemOur commitment is based on the research and development of treatments through the repositioning of drugs.
Spinal cord injury
Ictus
Other pathologies
Rimonabant
We currently have a clinical development program underway with rimonabant, aimed at treating fatigue and improving performance and quality of life in patients with Central Nervous System (CNS) diseases such as spinal cord injury or stroke, and in patients with persistent COVID or post-COVID syndrome.
Rimonabant is an antagonist/inverse agonist of endocannabinoid receptors located predominantly in the CNS. This drug has a well-established safety profile and is being evaluated in clinical trials for its repositioning as a possible treatment for fatigue and related functional symptoms caused by various CNS disorders.
Chemical structure of SR141716A (Rimonabant)
Contact form
Are you interested in learning more about Sinfatin and our developments?
We are here to help you. Write to us and we will respond as soon as possible.
We work to improve the lives of those living with central nervous system disorders by mitigating fatigue due to damage to motor systems.
Our commitment is to move toward more effective, safe, and accessible treatments.
